Dose-dense induction with sequential high-dose cytarabine and mitoxantone (S-HAM) and pegfilgrastim results in a high efficacy and a short duration of critical neutropenia in de novo acute myeloid leukemia: a pilot study of the AMLCG.
暂无分享，去创建一个
W. Hiddemann | S. Bohlander | C. Buske | K. Spiekermann | W. Kern | M. Fiegl | W. Ludwig | W. Berdel | H. Serve | J. Braess | A. Heinecke | T. Büchner | B. Wörmann | P. Staib | C. Sauerland | M. Unterhalt | D. Oruzio | X. Schiel | A. Reichle | A. Grüneisen | D. Beelen | C. Schmid | M. Hentrich | H. Baurmann | R. Peceny